Dr. Silfvast-Kaiser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2401 S 31st St
Temple, TX 76508Phone+1 254-724-2111
Summary
- After graduating from the University of Texas at Austin with a Bachelor of Science in Psychology and a Minor in Biology, I worked as Lead Medical Assistant at a private dermatology practice before pursuing my medical degree at Texas A&M College of Medicine. I completed my preliminary year in Internal Medicine at Baylor Scott & White in Temple, Texas and then began as the dermatology clinical research fellow at the Menter Dermatology Research Institute working with Dr. Alan Menter, a leader in psoriasis research. I served as the sub-investigator for numerous clinical trials in addition to writing and reviewing dermatologic manuscripts for peer-reviewed journals; publishing 20+ articles/book chapters during my time as a fellow. After completion of this 2-year clinical research fellowship, I continued my training in dermatology residency at Baylor University Medical Center in Dallas, Texas, completing my dermatology residency training at Baylor Scott & White in Temple, Texas where I will begin on staff in the Fall of 2023.
Education & Training
Texas A&M; Health Science Center College of MedicineClass of 2017
University of TexasBS, Psychology, 2007 - 2011
Certifications & Licensure
TX State Medical License 2018 - 2026- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Honors in Internal Medicine Clerkship Texas A&M College of Medicine, 2016
- Honors in Surgical Clerkship Texas A&M College of Medicine, 2015
- TAFP Foundation Preceptorship Scholarship TAFP Foundation, 2014
Publications & Presentations
PubMed
- 4 citationsHow can we manage the safety concerns associated with the increase in biologics for psoriasisAnnika Silfvast-Kaiser, Martin Alan Menter
Expert Opinion on Drug Safety. 2020-01-31 - 59 citationsAnti-IL17 therapies for psoriasis.Annika Silfvast-Kaiser, So Yeon Paek, Alan Menter
Expert Opinion on Biological Therapy. 2019-01-01 - 7 citationsAdams–Oliver Syndrome Type 2 in Association with Compound Heterozygous DOCK6 MutationsKrystal M. Jones, Annika Silfvast-Kaiser, David R. Leake, Lucia Z. Diaz, Moise L. Levy
Pediatric Dermatology. 2017-09-01
Journal Articles
- Diffuse dermal angiomatosis of the breastNguyen N, Silfvast-Kaiser A, Frieder J, Zaayman M, Menter A, Baylor University Medical Center Proceedings, 4/2020
- How can we manage the safety concerns associated with the increase in biologics for psoriasis?Silfvast-Kaiser A & Menter A, Expert Opinion on Drug Safety, 1/31/2020
- An unusual presentation of cutaneous sarcoidosisClifford G, Silfvast-Kaiser A, Paek SY, Dermatologic Therapy, 2020
- Join now to see all
Books/Book Chapters
Research History
- Dermatology Clinical Research Fellow2018 - 2020
Professional Memberships
- Member
- Member
- Texas Dermatological SocietyMember
- Dallas Dermatological SocietyMember
Other Languages
- Swedish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
